Your daily Selection of IRIN Africa PlusNews reports, 1/26/2005

[Guest guest]

U N I T E D N A T I O N S

Office for the Coordination of Humanitarian Affairs

Integrated Regional Information Network

[These reports do not necessarily reflect the views of the United Nations]

CONTENT:

1 - AFRICA: WHO's '3 by 5' plan gains momentum

1 - AFRICA: WHO's '3 by 5' plan gains momentum

JOHANNESBURG, 26 January (PLUSNEWS) - The second half of 2004 was a busy

time for African governments as they cranked up the roll out of anti-AIDS

drugs to their HIV-positive citizens.

In sub-Saharan Africa the number of people on antiretroviral (ARV)

treatment doubled in just six months with up to 310,000 people on

medication by December 2004, and there are now well over 700 sites in the

region that can deliver ARVs.

The World Health Organisation (WHO) and UNAIDS on Wednesday released the

second progress report on the '3 by 5' initiative - three million people

in the developing world on ARV therapy by the end of 2005 - at the World

Economic Forum meeting in Switzerland.

According to the report, in Botswana, Kenya, South Africa, Uganda and

Zambia the number of people on ARVs rose by more than 10,000 in each

country; more than a quarter of all people who need treatment in Uganda,

Namibia and Botswana are currently receiving it.

Despite these inroads, overall coverage in sub-Saharan Africa was still

low - just 8 percent, the report warned. Up to 5.1 million adults need

treatment in 2005 - 72 percent of them in this region.

" The figures speak for themselves - global progress towards the '3 by 5'

target can only be made if major progress is made in the countries with

the greatest unmet need for treatment, " the organisations commented.

Financial constraints remain a major hurdle, particularly the cost of ARV

medicines to countries. The report estimated that to reach '3 by 5' would

require about US $3.8 billion this year, but a study released by the

international NGO, Action Aid, has warned that WHO is facing a $2 billion

funding shortfall, which could knock off course its ability to meet its

commitments.

WHO and UNAIDS called for more people to come forward for testing and

counselling, to improve access to treatment. But children had been

" tragically neglected " and there were few programmes for treating them.

Dr Goemaere, head of Medecins Sans Frontieres (MSF) in South Africa,

agreed: " It's a scandal that the majority of provinces [in the country]

are hardly treating children. "

Treating them is difficult. Pharmaceutical companies have not yet

developed fixed-dose combination treatments in dosages appropriate for

children, and physicians often have to portion out a cocktail of three

separate adult-dose medicines in different combinations as the child

grows.

To determine correct paediatric doses most effectively, caregivers should

ideally use the three drugs according to the surface area of the child - a

number obtained by a complicated formula of multiplying the child's weight

by its length, dividing by 3,600, and then taking the square root of that

number.

The UN Children's Fund (UNICEF) and WHO have convened a meeting to plan

the development of paediatric ARV formulations that will be simpler and

more practical to use, said the report.

While access to treatment was expanding, the lack of skilled healthcare

workers presented another challenge - as many as 100,000 trained

healthcare workers were needed to handle the growing national programmes,

the study pointed out.

Goemaere warned that centralised and hospital-based treatment programmes

would not be sustainable. " If want this to last, and to have an impact on

prevention, we need to make this as simple as possible, so that everybody

can do it - not just doctors, " he told PlusNews.

People had to be treated at community level. " A lot of people are not able

to come to a large hospital which is the central designated ARV site - the

transportation fees, the distance ... in the long run, they will drop

out. "

Zambia's rapidly expanding rollout was a case in point, HIV-positive

activist Winston Zulu noted. " Even though the drugs are free, you still

have to pay for all the tests that come with being on ARVs, and you still

have to travel to get them. "

According to Zulu, it was " not just a question of numbers, we need to do

it right. "

" Enrolling 2.3 million new people on ARV therapy [in 2005] is clearly the

most difficult task the global public health community has ever faced.

However, we should be encouraged by the rapid progress we have witnessed

in the last six months, " the report observed.

Goemaere admitted that the target would be difficult to achieve, " but it's

good to have an ambitious target. People are under pressure to move, and

things are moving - and moving fast. "

To access the report:

http://www.who.int/3by5/en/ProgressReportfinal.pdf

[ENDS]

We have sent this message from a no-reply address to avoid bounced

messages into our general email folder. Please do not hesitate to contact

us at Mail@... with any comments or questions you may have

[This Item is Delivered to the English Service of the UN's IRIN

humanitarian information unit, but may not necessarily reflect the views

of the United Nations. For further information, free subscriptions, or

to change your keywords, contact e-mail: Irin@... or Web:

http://www.irinnews.org . If you re-print, copy, archive or re-post

this item, please retain this credit and disclaimer. Reposting by

commercial sites requires written IRIN permission.]

Copyright © UN Office for the Coordination of Humanitarian Affairs 2005

IRIN Contacts:

IRIN-Asia

Tel: +90 312 454 1177

Fax: +90 312 495 4166

Email: IrinAsia@...

To make changes to or cancel your subscription visit:

http://www.irinnews.org/subscriptions

Subscriber: AIDS treatments